Prosecution Insights
Prosecution Insights
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §102 only | 1 (17%) |
| Double-patenting only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIANO, JOSEPH PAUL | 1 | 36.1% | +64.0% |
| MCLEOD, AFRICA MHAIRIE | 1 | 50.0% | +73.0% |
| BERTOGLIO, VALARIE E | 1 | 63.9% | +30.3% |
| CHEN, STACY BROWN | 1 | 66.0% | +40.4% |
| ARIETI, RUTH SOPHIA | 1 | 45.3% | +72.1% |
| SHIN, DANA H | 1 | 27.0% | +27.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18183082 | RNA ENCODING A TUMOR ANTIGEN | SHIN, DANA H | 58d overdue |
| 18415477 | ARTIFICIAL NUCLEIC ACID MOLECULES | BERTOGLIO, VALARIE E | 11d overdue |
| 18705499 | IMPROVED CIRCULAR RNA FOR EXPRESSING THERAPEUTIC PROTEINS | MIANO, JOSEPH PAUL | — |
| 18283601 | IMMUNOGENIC COMPOSITIONS | CHEN, STACY BROWN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18183082 | RNA ENCODING A TUMOR ANTIGEN | SHIN, DANA H | 58d overdue |
| 18415477 | ARTIFICIAL NUCLEIC ACID MOLECULES | BERTOGLIO, VALARIE E | 11d overdue |
| 18705499 | IMPROVED CIRCULAR RNA FOR EXPRESSING THERAPEUTIC PROTEINS | MIANO, JOSEPH PAUL | — |
| 18293593 | CAP ANALOGS HAVING AN ACYCLIC LINKER TO THE GUANINE DERIVATIVE NUCLEOBASE | MCLEOD, AFRICA MHAIRIE | — |
| 18283601 | IMMUNOGENIC COMPOSITIONS | CHEN, STACY BROWN | — |
| 18315781 | METHOD FOR PRODUCING RNA MOLECULE COMPOSITIONS | ARIETI, RUTH SOPHIA | — |
| Art Unit | Apps |
|---|---|
| 1635 | 2 |
| 1632 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18705499 | IMPROVED CIRCULAR RNA FOR EXPRESSING THERAPEUTIC PROTEINS | MIANO, JOSEPH PAUL | — | §102§103 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18293593 | CAP ANALOGS HAVING AN ACYCLIC LINKER TO THE GUANINE DERIVATIVE NUCLEOBASE | MCLEOD, AFRICA MHAIRIE | — | §102 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18415477 | ARTIFICIAL NUCLEIC ACID MOLECULES | BERTOGLIO, VALARIE E | 1632 | §103§112 | Final Rejection | 11d overdue | Pending | Jan 17, 2024 |
| 18283601 | IMMUNOGENIC COMPOSITIONS | CHEN, STACY BROWN | 1672 | §101§102DP | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18315781 | METHOD FOR PRODUCING RNA MOLECULE COMPOSITIONS | ARIETI, RUTH SOPHIA | 1635 | §103§112DP | Non-Final OA | — | Pending | May 11, 2023 |
| 18183082 | RNA ENCODING A TUMOR ANTIGEN | SHIN, DANA H | 1635 | DP | Final Rejection | 58d overdue | Pending | Mar 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial